Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |